Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Non-Small-Cell Lung

Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.

4,700 public trials 1,041 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Non-Small-Cell Lung trial results

Completed

Study of Pembrolizumab/Vibostolimab Coformulation (MK-7684A) in Combination With Chemotherapy Versus Pembrolizumab Plus Chemotherapy in Participants With Metastatic Non-Small Cell Lung Cancer (MK-7684A-007/KEYVIBE-007)

NCT05226598

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • UCHealth Memorial Hospital-Heme Onc ( Site 0003) Colorado Springs, Colorado, United States
  • University of Colorado Health - Harmony-Cancer Care and Hematology - Ft. Collins ( Site 0031) Fort Collins, Colorado, United States
  • Mayo Clinic in Florida ( Site 0022) Jacksonville, Florida, United States
  • Mount Sinai Hospital ( Site 0011) Chicago, Illinois, United States
View all 149 locations
View Trial Details
Completed

A Study of Local Ablative Therapy (LAT) in People With Non-Small Cell Lung Cancer (NSCLC)

NCT05429320

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +17 more
Locations
  • Hartford Healthcare ALLIANCE (Data collection only) Hartford, Connecticut, United States
  • BAPTIST ALLIANCE - MCI (Data collection only) Miami, Florida, United States
  • Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
View Trial Details
Completed

A Study of Tiragolumab in Combination With Atezolizumab Compared With Placebo in Combination With Atezolizumab in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic PD-L1-Selected Non-Small Cell Lung Cancer

NCT04294810

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Rocky Mountain Cancer Center - Denver Denver, Colorado, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • SCRI Florida Cancer Specialists North St. Petersburg, Florida, United States
  • SCRI Florida Cancer Specialists PAN Tallahassee, Florida, United States
View all 134 locations
View Trial Details
Completed

A Study Comparing Sotorasib With Durvalumab in People With Non-Small Cell Lung Cancer (NSCLC)

NCT06333678

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • University of Miami (Data Collection Only) Miami, Florida, United States
  • University of Michigan (Data Collection Only) Ann Arbor, Michigan, United States
  • Memorial Sloan Kettering Basking Ridge (All Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (All Protocol Activities) Middletown, New Jersey, United States
View Trial Details
Completed

This Study Tests the New Medicine BI 754111 Alone or in Combination With Another New Substance BI 754091 in Patients With Advanced Cancer. The Study Tests Different Doses to Find the Best Dose for Continuous Treatment.

NCT03156114

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • University of Miami Miami, Florida, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
  • John Theurer Cancer Center Hackensack, New Jersey, United States
  • Stephenson Cancer Center Oklahoma City, Oklahoma, United States
View all 15 locations
View Trial Details
Completed

A Study of LY2875358 in Participants With Non-Small Cell Lung Cancer With Activating Epidermal Growth Factor Receptor Mutations

NCT01897480

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Herlev and Gentofte Hospital Herlev, Capital Region, Denmark
  • Rigshospitalet Copenhagen, Denmark
  • Odense Universitetshospital Odense C, Syd, Denmark
  • CHU de Caen Hopital Cote de Nacre Caen, France
View all 45 locations
View Trial Details
Completed

Pembrolizumab + Imprime PGG for Metastatic Non-small Cell Lung Cancer After Progression on First-Line Therapy: Big Ten Cancer Research Consortium BTCRC-LUN15-017

NCT03003468

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • University of Illinois at Chicago Chicago, Illinois, United States
  • Indiana Univeristy Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States
  • University of Iowa Hospital and Clinics Iowa City, Iowa, United States
  • Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
View Trial Details

Related conditions